Babraham Â鶹ÊÓƵ Modern Slavery & Human Trafficking Statement for April 2023 - March 2024
Introduction
This Modern Slavery and Human Trafficking Statement relates to actions and activities for the financial year 1st April 2023 to 31st March 2024. The statement sets down Â鶹ÊÓƵ’s commitment to preventing slavery and human trafficking in our business activities. Further it describes the steps we have put in place to ensure that there is no modern slavery or human trafficking in our own business or supply chains. We all have a duty to be alert to risks, however small. Staff are expected to report their concerns and management to act upon them.
Our Organisation
Â鶹ÊÓƵ is a world-class research institution, situated at the heart of the Babraham Research Campus, near Cambridge. Our mission is to be an international leader in research focusing on basic cell and molecular biology with an emphasis on healthy ageing through the human lifecycle. The Â鶹ÊÓƵ's research is supported by strategic funding from the Biotechnology and Biological Sciences Research Council who fund our three core areas of research: epigenetics, lymphocyte signalling and signalling. The Â鶹ÊÓƵ receives additional funding from other bodies including the Medical Research Council, Wellcome and the European Commission. Funding is also obtained through research collaborations with industry and medical charities.
Â鶹ÊÓƵ is committed to the principles of the Modern Slavery Act 2015 and the abolition of modern slavery and human trafficking, maintaining a Code of Conduct and Whistleblowing Policy as part of a wider suite of policies, all of which are easily accessible by all Â鶹ÊÓƵ staff and are regularly reviewed.
Our People
Our recruitment and people management processes are designed to ensure that all prospective employees are legally entitled to work in the UK and to safeguard employees from any abuse or coercion as a Babraham Â鶹ÊÓƵ employee.
Our Supply Chain
Â鶹ÊÓƵ procurement for goods and services is provided by a range of suppliers. The contractual terms and conditions in place with third parties are regularly reviewed and have been updated to include provisions designed to ensure that any risks of modern slavery are appropriately and effectively addressed.
Training
To ensure a good understanding of the risks of modern slavery and human trafficking in our business and supply chains, the Â鶹ÊÓƵ ensures key personnel across the business have awareness.
Due Diligence
Â鶹ÊÓƵ is committed to ensuring that any third parties we engage with adhere to the highest standard of ethics and continual review of both existing suppliers and new suppliers.
Approval
This statement has been approved by Â鶹ÊÓƵ
30 July 2024
Simon Jones
Company Secretary/Chief Operating Officer